DOC2b Enrichment Mitigates Proinflammatory Cytokine-induced CXCL10 Expression by Attenuating IKKβ and STAT-1 Signaling in Human Islets

Overview

Journal Metabolism

Date 2025 Jan 13

PMID 39805534

Authors

Diti Chatterjee Bhowmick

Miwon Ahn

Supriyo Bhattacharya

Arianne Aslamy

Debbie C Thurmond

Affiliations

Soon will be listed here.

Abstract

Introduction: Type 1 diabetic human islet β-cells are deficient in double C 2 like domain beta (DOC2b) protein. Further, DOC2b protects against cytokine-induced pancreatic islet β-cell stress and apoptosis. However, the mechanisms underpinning the protective effects of DOC2b remain unknown.

Methods: Biochemical studies, qPCR, proteomics, and immuno-confocal microscopy were conducted to determine the underlying protective mechanisms of DOC2b in β-cells. DOC2b-enriched or -depleted primary islets (human and mouse) and β-cell lines challenged with or without proinflammatory cytokines, global DOC2b heterozygous knockout mice subjected to multiple-low-dose-streptozotocin (MLD-STZ), were used for these studies.

Results: A significant elevation of stress-induced CXCL10 mRNA was observed in DOC2b-depleted β-cells and primary mouse islets. Further, DOC2b enrichment markedly attenuated cytokine-induced CXCL10 levels in primary non-diabetic human islets and β-cells. DOC2b enrichment also reduced total-NF-κB p65 protein levels in human islets challenged with T1D mimicking proinflammatory cytokines. IKKβ, NF-κB p65, and STAT-1 are capable of associating with DOC2b in cytokine-challenged β-cells. DOC2b enrichment in cytokine-stressed human islets and β-cells corresponded with a significant reduction in activated and total IKKβ protein levels. Total IκBβ protein was increased in DOC2b-enriched human islets subjected to acute cytokine challenge. Cytokine-induced activated and total STAT-1 protein and mRNA levels were markedly reduced in DOC2b-enriched human islets. Intriguingly, DOC2b also prevents ER-stress-IKKβ and STAT-1 crosstalk in the rat INS1-832/13 β-cell line.

Conclusion: The mechanisms underpinning the protective effects of DOC2b involve attenuation of IKKβ-NF-κB p65 and STAT-1 signaling, and reduced CXCL10 expression.

References

Aslamy A, Oh E, Olson E, Zhang J, Ahn M, Moin A . Doc2b Protects β-Cells Against Inflammatory Damage and Enhances Function. Diabetes. 2018; 67(7):1332-1344. PMC: 6014558. DOI: 10.2337/db17-1352. View

Ramalingam L, Oh E, Yoder S, Brozinick J, Kalwat M, Groffen A . Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity. Diabetes. 2012; 61(10):2424-32. PMC: 3447898. DOI: 10.2337/db11-1525. View

Burke S, Karlstad M, Eder A, Regal K, Lu D, Burk D . Pancreatic β-Cell production of CXCR3 ligands precedes diabetes onset. Biofactors. 2016; 42(6):703-715. PMC: 5177512. DOI: 10.1002/biof.1304. View

Sarkar S, Lee C, Victorino F, Nguyen T, Walters J, Burrack A . Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes. 2012; 61(2):436-46. PMC: 3266427. DOI: 10.2337/db11-0853. View

Salem H, Trojanowski B, Fiedler K, Maier H, Schirmbeck R, Wagner M . Long-term IKK2/NF-κB signaling in pancreatic β-cells induces immune-mediated diabetes. Diabetes. 2013; 63(3):960-75. DOI: 10.2337/db13-1037. View

Eizirik D, Sandler S, Welsh N, Cetkovic-Cvrlje M, Nieman A, Geller D . Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest. 1994; 93(5):1968-74. PMC: 294304. DOI: 10.1172/JCI117188. View

Aslamy A, Oh E, Ahn M, Moin A, Chang M, Duncan M . Exocytosis Protein DOC2B as a Biomarker of Type 1 Diabetes. J Clin Endocrinol Metab. 2018; 103(5):1966-1976. PMC: 6276681. DOI: 10.1210/jc.2017-02492. View

Aslamy A, Thurmond D . Exocytosis proteins as novel targets for diabetes prevention and/or remediation?. Am J Physiol Regul Integr Comp Physiol. 2017; 312(5):R739-R752. PMC: 5451566. DOI: 10.1152/ajpregu.00002.2017. View

Meier-Soelch J, Mayr-Buro C, Juli J, Leib L, Linne U, Dreute J . Monitoring the Levels of Cellular NF-κB Activation States. Cancers (Basel). 2021; 13(21). PMC: 8582385. DOI: 10.3390/cancers13215351. View

10.

Hohmeier H, Mulder H, Chen G, Prentki M, Newgard C . Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes. 2000; 49(3):424-30. DOI: 10.2337/diabetes.49.3.424. View

11.

Schulthess F, Paroni F, Sauter N, Shu L, Ribaux P, Haataja L . CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab. 2009; 9(2):125-39. DOI: 10.1016/j.cmet.2009.01.003. View

12.

Benaglio P, Zhu H, Okino M, Yan J, Elgamal R, Nariai N . Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokines. Cell Genom. 2023; 2(12):100214. PMC: 9903835. DOI: 10.1016/j.xgen.2022.100214. View

13.

Pearson J, Wong F, Wen L . The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. J Autoimmun. 2015; 66:76-88. PMC: 4765310. DOI: 10.1016/j.jaut.2015.08.019. View

14.

Bhowmick D, Burnett L, Kudaibergenova Z, Jeremic A . FoxA2 and RNA Pol II mediate human islet amyloid polypeptide turnover in ER-stressed pancreatic β-cells. Biochem J. 2021; 478(6):1261-1282. PMC: 8011634. DOI: 10.1042/BCJ20200984. View

15.

Bender C, Christen S, Scholich K, Bayer M, Pfeilschifter J, Hintermann E . Islet-Expressed CXCL10 Promotes Autoimmune Destruction of Islet Isografts in Mice With Type 1 Diabetes. Diabetes. 2016; 66(1):113-126. DOI: 10.2337/db16-0547. View

16.

Li F, Mahato R . iNOS gene silencing prevents inflammatory cytokine-induced beta-cell apoptosis. Mol Pharm. 2008; 5(3):407-17. DOI: 10.1021/mp700145f. View

17.

Evans-Molina C, Sims E, DiMeglio L, Ismail H, Steck A, Palmer J . β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis. JCI Insight. 2018; 3(15). PMC: 6129118. DOI: 10.1172/jci.insight.120877. View

18.

Siljander H, Hermann R, Hekkala A, Lahde J, Tanner L, Keskinen P . Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity. Eur J Endocrinol. 2013; 169(4):479-85. DOI: 10.1530/EJE-13-0206. View

19.

Oram R, Jones A, Besser R, Knight B, Shields B, Brown R . The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia. 2013; 57(1):187-91. PMC: 3855529. DOI: 10.1007/s00125-013-3067-x. View

20.

Chan J, Biden T, Laybutt D . Cross-talk between the unfolded protein response and nuclear factor-κB signalling pathways regulates cytokine-mediated beta cell death in MIN6 cells and isolated mouse islets. Diabetologia. 2012; 55(11):2999-3009. DOI: 10.1007/s00125-012-2657-3. View